Musculoskeletal pain may be associated with imatinib withdrawal syndrome in chronic myeloid leukemia patients

Yoshimi IshiiDepartment of Hematology, Yokohama City University Medical Center, Yokohama, JapanCorrespondence[email protected]

Maki HagiharaDepartment of Hematology, Yokohama City University Medical Center, Yokohama, Japan

Ai KatoDepartment of Hematology, Yokohama City University Medical Center, Yokohama, Japan

Taiki AndoDepartment of Hematology, Yokohama City University Medical Center, Yokohama, Japan

Megumi ItabashiDepartment of Hematology, Yokohama City University Medical Center, Yokohama, Japan

Satoshi KoyamaDepartment of Hematology, Yokohama City University Medical Center, Yokohama, Japan

Wataru YamamotoDepartment of Hematology, Yokohama City University Medical Center, Yokohama, Japan

Kenji MotohashiDepartment of Hematology, Yokohama City University Medical Center, Yokohama, Japan

Kenji MatsumotoDepartment of Hematology, Yokohama City University Medical Center, Yokohama, Japan

Shin FujisawaDepartment of Hematology, Yokohama City University Medical Center, Yokohama, Japan

show all

References

Faderl S, Talpaz M, Estrov Z, et al. The biology of chronic myeloid leukemia. N Engl J Med 1999;341:164–172.
PubMed Web of Science ®Google Scholar
Baccarani M, Cortes J, Pane F, et al. Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet. J Clin Oncol 2009;27:6041–6051.
PubMed Web of Science ®Google Scholar
Rousselot P, Charbonnier A, Cony-Makhoul P, et al. Loss of major molecular response as a trigger for restarting tyrosine kinase inhibitor therapy in patients with chronic-phase chronic myelogenous leukemia who have stopped imatinib after durable undetectable disease. J Clin Oncol 2014;32:424–430.
PubMed Web of Science ®Google Scholar
Richter J, Söderlund S, Lübking A, et al. Musculoskeletal pain in patients with chronic myeloid leukemia after discontinuation of imatinib: a tyrosine kinase inhibitor withdrawal syndrome? J Clin Oncol 2014;32:2821–2823.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Musculoskeletal pain may be associated with imatinib withdrawal syndrome in chronic myeloid leukemia patients

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Musculoskeletal pain may be associated with imatinib withdrawal syndrome in chronic myeloid leukemia patients

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date